Inflammatory Bowel Disease and Helicobacter pylori: Protective or Present?

Samuel Tanner; Jeffry Katz; Fabio Cominelli; Miguel Regueiro; Gregory Cooper; Emad Mansoor

doi:10.1093/ibd/izac202

Inflammatory Bowel Disease and Helicobacter pylori: Protective or Present?

Inflamm Bowel Dis. 2023 Jun 1;29(6):1005-1007. doi: 10.1093/ibd/izac202.

Authors

Samuel Tanner¹, Jeffry Katz², Fabio Cominelli², Miguel Regueiro³, Gregory Cooper², Emad Mansoor²

Affiliations

¹ Department of Internal Medicine, University Hospitals Cleveland Medical Center, Cleveland, Ohio, USA.
² Division of Gastroenterology and Liver Disease, University Hospitals Cleveland Medical Center, Cleveland, Ohio, USA.
³ Department of Gastroenterology, Hepatology & Nutrition, Cleveland Clinic Foundation, Cleveland, Ohio, USA.

PMID: 36169397
DOI: 10.1093/ibd/izac202

No abstract available

Keywords: Helicobacter pylori; Crohn disease; autoimmune diseases; inflammatory bowel disease; ulcerative colitis.

Plain language summary

This article describes the prevalence of inflammatory bowel disease in patients with gastritis, duodenitis, and peptic ulcer disease, stratified by Helicobacter pylori infection. Inflammatory boweld is less prevalent in patients with H. pylori, and no increased risk of IBD is seen after H. pylori eradication therapy.

MeSH terms

Crohn Disease*
Helicobacter Infections* / complications
Helicobacter pylori*
Humans
Inflammatory Bowel Diseases*